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Campomelic dysplasia (CD), a semilethal human skeletal
malformation syndrome with XY sex reversal, is caused
by heterozygous mutations in the SRY-related transcrip-
tion factor gene SOX9 (Foster et al., 1994; Wagner et al.,
1994). The mouse Sox9 gene, located on distal chromo-
some 11, is expressed during chondrogenesis (Wright et
al., 1995), and is a key regulator of cartilage differentia-
tion (Bi et al., 1999) and testis development (Vidal et al.,
2001). Sox9 is expressed in a variety of embryonic tis-
sues (Ng et al., 1997), suggesting further functions for
Sox9/SOX9 during organogenesis. Indeed, CD patients
show malformations in nonskeletal organs such as brain,
heart, and kidneys (Houston et al., 1983; Mansour et al.,
1995).
Recently, Sox9/ mutant mice have been generated
by a classical gene targeting approach and were shown
to phenocopy the skeletal malformations observed in CD
(Bi et al., 2001). However, because Sox9/ mice die
shortly after birth, it was not possible to generate a stable
Sox9 mutant mouse line. To circumvent this problem
and to provide a tool for an in-depth analysis of Sox9
functions in skeletal development and the formation of
other organs, we have generated a conditional Sox9
mutant allele in mice using the Cre/loxP system (Nagy,
2000; Le and Sauer, 2001) (Fig.1). Five correctly targeted
embryonic stem (ES) cell clones were identified, and,
following successful deletion of the neo cassette by
transient in vitro expression of Cre recombinase (Ta-
niguchi et al., 1998), two clones were microinjected into
C57BL/6 blastocysts. Germline transmission was ob-
tained for both clones and two Sox9-flox mouse lines
have been established by backcrossing to C57BL/6 mice.
Both Sox9flox/flox homozygous male and female mice are
viable and fertile and do not show any obvious pheno-
type.
To test for conditional inactivation of Sox9 in vivo,
Sox9/flox mice were crossed to Cre deleter mice which
ubiquitously express the Cre recombinase (Schwenk et
al., 1995) (Fig 2a). In Sox9/flox; Cre–transgenic animals,
designated as Sox9/, exon 2 encoding half of the
DNA-binding high-mobility group (HMG) domain and
exon 3 encoding the entire transactivation domain are
deleted (Fig. 2a, b). Because the transactivation domain
is essential for SOX9 function (Su¨dbeck et al., 1996), and
because truncated HMG domains cannot bind to DNA
(Giese et al., 1991), our strategy most likely results in a
functional null allele of the Sox9 gene. Complete recom-
bination of the loxP-flanked Sox9 allele was demon-
strated by allele-specific PCR analysis of Sox9/ mu-
tants (Fig. 2c).
Sox9/ mice died shortly after birth, presumably
because of severe respiratory failure caused by a cleft
secondary palate. Skeletal staining of newborn Sox9/
mutants revealed bone malformations typically observed
in CD patients (Fig. 2 and data not shown). For example,
the scapula was hypoplastic and malformed and the
deltoid tuberosity of the humerus was missing (Fig. 2e).
In addition, premature mineralization occurred in many
skeletal elements, including the tail vertebrae (Fig. 2g).
This is in agreement with the recently proposed role for
Sox9 in regulating the rate of hypertrophic chondrocyte
differentiation (Bi et al., 2001).
Taken together, our analysis revealed that the skeletal
phenotype of conditional Sox9/ mutants is very simi-
lar to that described for Sox9/ mutants (Bi et al.,
2001). The different genetic background of mice used in
the two studies may account for minor differences we
observed in the severity of the skeletal phenotypes. The
availability of tissue-specific or inducible Cre-transgenic
mouse strains will make the conditional Sox9 allele a
valuable tool not only to understand cartilage differenti-
ation and skeletogenesis but also to investigate Sox9
functions during the development of a variety of other
organs during mammalian development.
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FIG. 1. Sox9 gene targeting strategy and Cre-mediated removal of the neo cassette in ES cells. (a) The targeting vector contained a
loxP-flanked MC1-neo-pA cassette (neo, open box) inserted into intron 1, a third loxP site inserted downstream of exon 3, and a PGK-tk-pA
negative selection cassette (tk, open box). After electroporation into E14.1 ES cells and following homologous recombination, the
loxP-flanked neo cassette was removed by transient expression of Cre recombinase. Grey boxes, Sox9 exons 1–3; triangles, loxP sites; A,
ApaI; B, BamHI; E, EcoRI; H, HindIII; K, KpnI; S, SalI. Expected restriction fragment sizes detected by the probes are indicated. (b–e)
Southern blot analyses of wild-type and modified Sox9 alleles. Homologous recombination was confirmed with external probe 1 (b) and
external, repetitive probe 2 (not shown). For clarity, internal probe 3 is shown (c); no additional bands were detected with this probe.
Because removal of the neo cassette creates an EcoRI fragment of close to wild-type size (d), presence of the 3 loxP site was confirmed
with probe 3 (e).
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FIG. 2. Sox9 inactivation by in vivo Cre-mediated recombination. (a) Schematic representation of Sox9 in vivo inactivation obtained by
crossing Sox9-flox mice with Cre deleter mice, resulting in deletion of exons 2 and 3. Grey boxes, exons 1–3; triangles, loxP sites;
arrowheads, PCR primers (5-3) F1: CTCCGGTAGCAAAGGCGTTTAG, F2: CCGGCTGCTGGGAAAGTATATG, R: CGCTGGTATTCAGG-
GAGGTACA; E, EcoRI; H, HindIII. Expected restriction fragment sizes detected by probe 1 are indicated. (b, c) Confirmation of
Cre-mediated ubiquitous deletion by Southern blot analysis of tail DNA (c) and by allele-specific PCR analysis of liver DNA (c). See (a) for
PCR primer combinations. (d–g) Alcian blue and Alizarin red skeletal stainings of Sox9/ newborn mice (e, g) and wild-type controls (d,
f). (e) Hypoplasia and malformation of scapula (arrow) and missing deltoid tuberosity of the humerus (arrowhead). (g) Premature
mineralization of tail vertebrae. Animals were on a mixed 129P2/OlaHsd  C57BL/6 genetic background.
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